Association between response to brief trastuzumab exposure in cell lines and early stage HER2+ breast tumors.
Emmett SprecherSudipa SarkarSteven H. KleinsteinMurli NarayanEric P. WinerDavid TuckKimberly Lezon-GeydaIan KropLyndsay HarrisPublished in: BCB (2011)